Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Discovery: Overview01:26

Drug Discovery: Overview

9.2K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
9.2K
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

1.1K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.1K
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

7.8K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
7.8K
Principles of Drug Action01:24

Principles of Drug Action

6.9K
Drugs are chemical substances that modify biological responses by interacting with macromolecular targets such as receptors, ion channels, transporters, and enzymes. Pharmacodynamics describes the course of action of drugs leading to the physiological effect at a specific site in the body.
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
6.9K
Drug Biotransformation: Overview01:16

Drug Biotransformation: Overview

3.0K
Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
3.0K
Protein Networks02:26

Protein Networks

4.1K
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
4.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Readiness-Efficiency Coupling: Synergy of High Preparatory and Reduced Execution Fractal Complexity in Motor Learning.

Journal of motor behavior·2026
Same author

Exploring the omnigenic architecture of selected complex traits.

American journal of human genetics·2025
Same author

Speos: an ensemble graph representation learning framework to predict core gene candidates for complex diseases.

Nature communications·2023
Same author

Interpreting the pervasive observation of U-shaped Site Frequency Spectra.

PLoS genetics·2023
Same author

The Role of Parkinson Nurses for Personalizing Care in Parkinson's Disease: A Systematic Review and Meta-Analysis.

Journal of Parkinson's disease·2022
Same author

Data-Powered Positive Deviance during the SARS-CoV-2 Pandemic-An Ecological Pilot Study of German Districts.

International journal of environmental research and public health·2021

Related Experiment Video

Updated: Oct 1, 2025

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports
07:35

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports

Published on: October 13, 2023

1.8K

Task-driven knowledge graph filtering improves prioritizing drugs for repurposing.

Florin Ratajczak1,2, Mitchell Joblin3, Martin Ringsquandl3

  • 1Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH), Munich, Germany. florin.ratajczak@helmholtz-muenchen.de.

BMC Bioinformatics
|March 5, 2022
PubMed
Summary

This study filters biomedical knowledge graphs using metapaths to improve drug repurposing predictions. Task-driven filtering enhances drug target identification and computational efficiency.

Keywords:
Drug repurposingKnowledge graph embeddingsKnowledge graphsLink prediction

More Related Videos

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.8K
Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
05:47

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems

Published on: June 13, 2025

642

Related Experiment Videos

Last Updated: Oct 1, 2025

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports
07:35

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports

Published on: October 13, 2023

1.8K
Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.8K
Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
05:47

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems

Published on: June 13, 2025

642

Area of Science:

  • Bioinformatics
  • Computational Biology
  • Pharmacology

Background:

  • Drug repurposing is crucial for cost-effective drug discovery.
  • Biomedical knowledge graphs integrate diverse biological data for predicting new drug-disease connections.
  • Existing knowledge graph embedding models may underfit specific tasks like drug repurposing due to optimizing over all relation types.

Purpose of the Study:

  • To develop a method for filtering biomedical knowledge graphs to improve drug repurposing.
  • To enhance the performance and computational efficiency of drug repurposing prediction models.
  • To leverage domain knowledge in the form of metapaths for task-specific knowledge graph refinement.

Main Methods:

  • Utilized metapaths to filter two large biomedical knowledge graphs: Hetionet and DRKG.
  • Applied a task-driven filtering approach to remove irrelevant information.
  • Evaluated the impact of filtering on drug repurposing prediction performance and computational efficiency.

Main Results:

  • The proposed method significantly reduced the number of entities in the knowledge graphs (up to 60% on Hetionet, 26% on DRKG).
  • Achieved substantial improvements in prediction performance (up to 40.8% on Hetionet, 14.2% on DRKG).
  • Demonstrated improved prioritization of antiviral compounds for SARS-CoV-2 following filtering.

Conclusions:

  • Biomedical knowledge graphs contain information detrimental to specific tasks like drug repurposing.
  • Task-driven filtering effectively removes counterproductive facts, enhancing prediction performance.
  • The filtering process leads to a more efficient learning process for drug repurposing models.